Outlook Therapeutics Overview
Outlook Therapeutics Target Price
Analysts' 12-month price predictions for OTLK.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.16
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-02 | Chardan CapitalDaniil Gataulin | $1 |  13.8% downside |  |
| 2025-08-29 | H.C. WainwrightDouglas Tsao | $1 | 13.8% downside | |